Aarti Drugs Limited

NSE: AARTIDRUGS · Unclassified

₹446.75+0.36%06 Nov 2026

Ask the data

Instant answers about Aarti Drugs Limited — computed from its filings, no language model

Market cap₹4,077 cr

Current price₹446.75

High / Low₹520 / ₹320

P/E17.8

P/B2.42

Book value₹184.2

ROE13.6%

ROCE13.7%

Debt / equity0.37

Dividend yield0.45%

EPS (TTM)₹25.07

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 9 periods

	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	1,263	1,561	1,806	2,155	2,489	2,716	2,529	2,387	2,565
EBITDA	198	207	262	437	329	306	316	287	309
Operating margin	15.7%	13.3%	14.5%	20.3%	13.2%	11.3%	12.5%	12.0%	12.1%
Interest	35	40	34	23	21	33	34	36	34
Depreciation	40	43	49	50	50	50	51	56	67
Profit before tax	125	131	185	369	270	224	236	212	211
Tax	42	41	44	89	65	58	64	44	16
Net profit	0	90	141	280	205	166	171	168	195
EPS ₹	34.41	38.48	60.57	30.09	22.12	17.97	18.56	18.35	21.36
Operating cash flow	—	—	—	—	70	134	359	245	254
Capex	—	—	—	—	144	165	226	177	173
Dividend paid	—	—	—	—	10	9	9	9	18
Total assets	—	—	—	—	—	2,421	2,432	2,575	2,815
Equity	—	—	—	—	—	1,192	1,282	1,369	1,549

Quarterly performance

last 33 quarters · ₹ crore

showing latest 8 of 33 periods

	MAR '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	331	347	380	459	405	478	474	450	545	578	530	502	580	580	635	694	688	664	742	661	642	606	620	591	598	557	677	591	653	602	720	703	826
Operating profit	57	47	52	56	55	68	67	71	134	116	106	81	80	74	90	86	74	71	94	84	76	70	86	74	67	62	93	74	84	55	96	98	135
Operating margin	17.1%	13.5%	13.6%	12.2%	13.5%	14.3%	14.3%	15.9%	24.6%	20.1%	19.9%	16.1%	13.7%	12.7%	14.2%	12.4%	10.8%	10.6%	12.6%	12.7%	11.9%	11.6%	13.8%	12.5%	11.2%	11.1%	13.8%	12.5%	12.9%	9.1%	13.3%	14.0%	16.4%
Other income	1	0	0	5	0	0	0	1	1	0	2	1	2	0	7	3	0	1	1	1	1	2	1	0	1	12	2	0	0	1	1	1	3
Interest	9	10	10	10	9	9	8	7	7	7	5	4	4	5	5	6	8	9	9	9	8	8	9	9	9	9	9	9	8	9	8	9	10
Depreciation	10	11	11	11	12	12	12	12	12	13	13	12	12	12	13	13	13	13	12	13	13	13	14	15	14	14	15	15	16	18	18	18	19
Profit before tax	38	27	31	40	34	48	43	61	116	97	90	65	65	56	79	70	53	50	73	64	56	52	64	51	46	51	71	51	60	29	70	69	109
Tax	14	9	10	12	11	16	15	2	31	22	22	14	16	14	20	15	14	13	17	16	17	15	17	-3	11	14	8	-3	15	-12	15	19	27
Net profit	0	0	0	27	0	0	28	59	85	75	68	52	49	43	58	55	39	37	56	48	40	37	47	54	35	37	63	54	45	41	55	50	83
EPS ₹	9.97	7.65	8.86	12.06	9.56	13.87	11.92	25.26	36.67	32.30	7.30	5.54	5.25	4.60	6.29	5.97	4.18	3.96	6.07	5.18	4.29	3.99	5.15	5.91	3.83	4.06	6.88	5.91	4.95	4.44	6.05	5.49	9.07
Revenue YoY	—	—	—	38.8%	—	37.4%	24.6%	-2.1%	34.3%	21.1%	12.0%	11.6%	6.5%	0.3%	19.7%	38.4%	18.7%	4.6%	6.9%	—	-6.7%	-8.7%	-16.5%	-10.7%	-6.7%	-8.1%	9.2%	0.0%	9.1%	8.1%	6.4%	19.0%	26.6%
Profit YoY	—	—	—	—	—	—	—	114.5%	—	—	144.9%	-12.2%	-42.9%	-43.4%	-14.3%	7.1%	-9.0%	-37.1%	1.4%	—	2.2%	-0.0%	-15.5%	12.4%	-11.6%	1.0%	32.7%	0.0%	29.3%	9.4%	-12.2%	-6.9%	83.2%

Earlier results (standalone, Sep '07 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Aarti Drugs Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

showing latest 8 of 9 periods

	FY09†	FY10†	FY11†	FY12†	FY13†	FY14†	FY15†	FY16†	FY17†
Revenue	394	479	506	653	826	972	1,085	1,076	1,092
Operating profit	58	72	60	74	120	146	169	172	178
Operating margin	14.7%	15.0%	11.9%	11.3%	14.6%	15.1%	15.6%	16.0%	16.3%
Other income	0	0	0	—	—	—	—	—	—
Interest	24	15	13	21	28	33	39	43	34
Depreciation	11	14	15	20	26	28	31	36	37
Profit before tax	23	44	31	32	66	85	100	93	107
Tax	8	18	9	10	21	23	22	27	32
Net profit	15	26	22	22	45	62	78	66	74

Quarters

showing latest 8 of 42 periods

	SEP '07†	DEC '07†	MAR '08†	JUN '08†	SEP '08†	DEC '08†	MAR '09†	JUN '09†	SEP '09†	DEC '09†	MAR '10†	JUN '10†	SEP '10†	DEC '10†	MAR '11†	JUN '11†	SEP '11†	DEC '11†	MAR '12†	JUN '12†	SEP '12†	DEC '12†	MAR '13†	JUN '13†	SEP '13†	DEC '13†	MAR '14†	JUN '14†	SEP '14†	DEC '14†	MAR '15†	JUN '15†	SEP '15†	DEC '15†	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†
Revenue	74	67	110	102	94	92	107	115	120	117	127	118	108	136	143	148	144	155	205	190	216	199	220	219	248	222	283	260	286	261	278	264	258	257	297	269	287	264	272	248	288	308
Operating profit	10	9	10	17	14	10	16	20	19	15	18	15	14	15	16	15	15	17	26	26	30	30	35	31	35	37	43	40	42	44	43	44	42	42	44	44	48	40	46	33	44	51
Operating margin	13.0%	13.5%	9.4%	17.2%	14.9%	10.9%	15.3%	17.0%	15.7%	12.6%	14.6%	12.9%	13.2%	11.2%	10.9%	10.1%	10.6%	11.0%	12.9%	13.6%	13.7%	15.0%	16.0%	14.1%	14.2%	16.9%	15.1%	15.3%	14.8%	16.8%	15.4%	16.5%	16.3%	16.5%	14.7%	16.3%	16.6%	15.3%	16.9%	13.4%	15.3%	16.5%
Other income	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	—	—	—	—	—	—	—	—	—	—	—	1	—	—	—	—	—	—	—	—	—	0	0	0
Interest	2	2	6	7	6	6	5	4	4	3	3	3	3	4	4	4	4	6	7	7	7	7	8	7	8	9	9	10	9	10	10	10	11	11	11	9	8	9	8	8	8	8
Depreciation	3	2	3	3	3	3	3	3	3	3	3	4	4	4	4	4	4	5	6	6	6	7	7	7	7	7	8	7	7	8	8	9	9	9	9	9	9	9	9	9	9	9
Profit before tax	5	5	3	8	5	1	8	12	12	8	12	9	8	8	7	7	7	7	12	13	17	16	21	17	21	21	26	23	26	27	25	25	23	22	23	25	30	22	29	16	27	33
Tax	1	1	1	2	2	1	4	5	5	4	5	3	2	3	1	2	2	2	5	4	5	5	7	5	7	7	4	5	7	4	6	8	7	6	6	8	10	6	9	5	9	11
Net profit	4	3	2	7	3	1	5	7	7	5	7	6	5	5	6	5	5	5	7	9	12	11	14	12	14	14	22	17	19	23	19	17	16	17	17	17	20	16	20	11	18	22
EPS ₹	3.45	2.80	1.60	5.57	2.92	0.47	3.90	6.24	5.79	3.96	5.97	4.94	4.28	—	5.19	3.81	4.07	3.97	6.11	7.33	9.59	9.04	11.40	9.78	11.36	11.69	18.13	14.24	15.49	18.79	7.79	7.04	6.41	6.86	7.07	7.16	8.30	6.75	8.57	4.43	7.56	9.23
Revenue YoY	—	—	—	—	27.3%	37.6%	-3.0%	13.0%	27.1%	27.7%	18.8%	2.9%	-9.4%	16.2%	12.9%	25.3%	33.3%	14.0%	43.1%	28.3%	49.8%	28.4%	7.4%	15.1%	14.6%	11.6%	28.4%	18.8%	15.5%	17.5%	-1.6%	1.5%	-10.0%	-1.7%	6.9%	2.1%	11.5%	2.9%	-8.6%	-7.8%	0.4%	16.6%
Profit YoY	—	—	—	—	-15.4%	-83.2%	143.9%	12.1%	98.8%	772.7%	58.6%	-18.2%	-23.5%	4.6%	-13.0%	-22.7%	-5.2%	-4.0%	18.0%	92.4%	136.4%	127.2%	86.1%	33.1%	18.3%	29.4%	58.9%	45.6%	36.2%	60.5%	-14.1%	-1.0%	-17.2%	-27.0%	-9.2%	1.7%	29.5%	-1.6%	19.5%	-39.0%	-10.3%	34.8%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 26 periods

	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	—	—	—	—	15.1%	14.9%	14.9%	13.4%	13.9%	13.5%	13.6%	13.8%	13.8%	13.6%	13.8%	12.6%	12.3%	13.6%
ROCE	—	—	—	—	—	—	—	—	—	—	—	—	15.3%	15.4%	15.5%	14.6%	13.9%	13.2%	13.3%	12.9%	12.9%	13.1%	12.1%	11.5%	12.4%	13.7%
Net margin	1.7%	1.6%	3.0%	4.8%	8.8%	12.1%	13.7%	13.0%	11.1%	9.6%	8.8%	8.2%	6.5%	6.7%	6.8%	6.8%	7.2%	7.2%	7.3%	7.8%	7.8%	8.0%	8.0%	7.6%	7.1%	8.0%
EBITDA margin	13.2%	13.4%	13.6%	14.5%	17.5%	19.0%	20.3%	20.3%	17.5%	15.5%	14.1%	13.2%	11.7%	12.0%	12.2%	12.5%	12.5%	12.3%	12.2%	12.2%	12.2%	12.7%	12.2%	12.1%	12.4%	13.5%
Debt / equity	—	—	—	—	—	—	—	—	—	—	—	—	0.51	0.49	0.49	0.44	0.44	0.46	0.46	0.45	0.45	0.39	0.39	0.37	0.37	0.37
Interest coverage	4.28	4.93	5.49	6.49	9.65	11.76	14.99	17.07	16.41	15.69	14.78	14.01	7.85	7.98	8.41	8.03	7.65	7.22	6.94	7.13	7.13	7.77	7.10	7.26	7.66	8.66
Asset turnover	—	—	—	—	—	—	—	—	—	—	—	—	1.14	1.15	1.13	1.04	1.01	0.99	0.97	0.94	0.94	0.95	0.97	0.91	0.95	0.93

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	93	93	92	92	91	91	91	91	91
Other equity / reserves	1,017	1,100	1,118	1,190	1,186	1,278	1,377	1,458	1,590
Total equity	1,110	1,192	1,209	1,282	1,277	1,369	1,468	1,549	1,682
Borrowings	582	607	587	562	588	612	571	575	619
Current liabilities	934	933	833	796	781	837	783	922	1,044
Non-current liabilities	225	296	309	355	371	368	361	344	328
Total assets	2,269	2,421	2,352	2,432	2,430	2,575	2,612	2,815	3,054
Property, plant & equipment	682	675	668	808	833	856	1,066	1,068	1,096
Capital work-in-progress	131	210	305	225	299	330	179	214	236
Investments	19	19	19	20	20	22	23	27	28
Inventories	581	516	515	486	470	473	470	491	603
Receivables	709	865	704	705	683	751	720	830	905
Cash & equivalents	15	9	13	7	11	5	7	7	8

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	70	134	359	245	254
Cash from investing	-149	-164	-224	-165	-173
Cash from financing	92	17	-136	-82	-77
Capex	144	165	226	177	173
Free cash flow	-74	-30	133	67	80
Dividends paid	10	9	9	9	18

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹1,096 cr36%

CWIP

₹236 cr8%

Investments

₹28 cr1%

Inventories

₹603 cr20%

Receivables

₹905 cr30%

Cash & equivalents

₹8 cr0%

Other assets

₹178 cr6%

Peer comparison

largest in Unclassified · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Avantel Limited	36,86,04,549	138.69	—	1059360.68	0.0%
Ducol Organics And Colours Limited	19,55,275	120.00	—	20089.13	0.0%
Jio Platforms Limited	12,57,181	1,406.40	—	3.57	—
SBI Funds Management Limited	1,01,750	499.55	—	—	—
Tamilnadu Telecommunication Limited	91,314	9.93	—	—	—
Manipal Health Enterprises Limited	76,294	646.70	—	—	—
INDO-MIM Limited	59,042	1,219.50	—	—	—
AvenuesAI Limited	45,138	129.25	153.6	9.51	6.2%
Dhoot Transmission Limited	32,761	1,601.60	—	8.11	—
3M India Limited	31,071	27,570.00	53.8	17.57	32.7%
Aarti Drugs Limited	4,077	446.75	17.8	2.42	13.6%

StoxGud checklist: Bullish setup · 7/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+7.0%

6 months+12.3%

1 year-9.6%

3Y CAGR-1.9%

5Y CAGR-4.6%

10Y CAGR+11.0%

50-day avg₹422.30

200-day avg₹390.63

RSI (14)65

FAQs

What is the share price of Aarti Drugs Limited?

Aarti Drugs Limited (AARTIDRUGS) closed at ₹446.75 on NSE on 06 Nov 2026.

What is the market cap of Aarti Drugs Limited?

₹4,077 crore at the latest close.

What is the P/E ratio of Aarti Drugs Limited?

17.8, on trailing-twelve-month earnings from its filings.

How fast is Aarti Drugs Limited growing?

Aarti Drugs Limited: revenue has compounded at -1.9% a year over three years; net profit at 5.4% a year. Latest-quarter revenue is up 26.6% year on year, profit up 83.2%.

How profitable is Aarti Drugs Limited?

On a trailing-twelve-month basis return on equity is 13.6%, return on capital employed 13.7%, operating margin 13.5%, net margin 8.0%.

How much debt does Aarti Drugs Limited have?

Aarti Drugs Limited is lightly geared: debt to equity is 0.37 with borrowings of ₹619 cr against cash of ₹8 cr (balance sheet of 2026-09-30). Operating profit covers interest 8.7 times.

Financials parsed from Aarti Drugs Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.